InfliximabPsoriasis: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2013年 / 1452卷 / 1期

关键词：

D O I：

10.1007/s40278-013-3158-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：25 / 25

相关论文

共 50 条

[21] Adalimumab/efalizumab/infliximabPsoriasis: 5 case reports
Reactions Weekly, 2008, 1210 (1) : 5 - 5
[22] Adalimumab/etanercept/infliximabPsoriasis: 4 case reports
Reactions Weekly, 2008, 1209 (1) : 6 - 6
[23] Adalimumab/etanercept/infliximabPsoriasis: 6 case reports
Reactions Weekly, 2013, 1438 (1) : 5 - 5
[24] Adalimumab/etanercept/infliximabPsoriasis: 25 case reports
Reactions Weekly, 2009, 1241 (1) : 6 - 6
[25] Adalimumab/infliximabPsoriasis and psoriasisiform exanthema: 6 case reports
Reactions Weekly, 2008, 1184 (1) : 6 - 6
[26] Adalimumab/etanercept/infliximabPsoriasis and psoriasiform lesions: 7 case reports
Reactions Weekly, 2013, 1450 (1) : 5 - 5
[27] Adalimumab/etanercept/infliximabPsoriasis or psoriasis reactivation: 15 case reports
Reactions Weekly, 2008, 1210 (1) : 6 - 6
[28] Adalimumab/certolizumab pegol/infliximabPsoriasis and psoriasiform eruptions: 14 case reports
Reactions Weekly, 2017, 1660 (1) : 16 - 16
[29] InfliximabPsoriasis: case report
Reactions Weekly, 2024, 2023 (1) : 203 - 203
[30] InfliximabPsoriasis: case report
Reactions Weekly, 2011, 1364 (1) : 28 - 28

← 1 2 3 4 5 →